FibroGen Inc
FGEN
Market Cap$31.12M
Close$
$3.46
1025% upside
Current Fair Value
1025% upsideUndervalued by 1025% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $31.12 Million |
|---|---|
| Enterprise Value | $81.02 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.48 |
| Beta | 0.87 |
| Outstanding Shares | 100,830,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.65 |
|---|---|
| PEG | 0.89 |
| Price to Sales | 0.31 |
| Price to Book Ratio | -0.15 |
| Enterprise Value to Revenue | 0.45 |
| Enterprise Value to EBIT | -0.72 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.24 |
| Debt to Equity | -0.44 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About FibroGen Inc
CEO: Enrique Conterno